DYnamic decisioN Support for IntegrAting PrEP in Clinics for Young People in Alabama and Botswana
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT07597824
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Contraception
- HIV Infections
- PrEP
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Observational cohort (PrEP use in real-world settings) — OTHERNo intervention
Study Details
This study evaluates strategies to improve access to HIV prevention through the integration of pre-exposure prophylaxis (PrEP) into existing healthcare settings, rather than limiting delivery to specialty clinics. The study addresses barriers to PrEP uptake, including limited awareness, stigma, and restricted access, and recognizes that availability alone may not ensure initiation or sustained use. The study includes two components. First, a longitudinal cohort of current PrEP users will be followed to assess changes in access, preferences, and PrEP use over time in real-world settings. Second, a dynamic decision-support toolkit will be developed and evaluated to support patients and providers in PrEP-related decision-making. The toolkit will include patient- and provider-facing components to support clinical decision-making, improve risk understanding, and facilitate integration of PrEP into routine healthcare. The toolkit will be refined and beta-tested in selected healthcare facilities in Botswana and Alabama.
Key Dates
- First listed
- May 19, 2026
- Start date
- Jun 30, 2026
- Status verified
- May 2026
- Primary completion
- Dec 31, 2031
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Group 1: Adults Using or Eligible for PrEPPrEP users - Individuals aged 18 years or older who are currently using or eligible for PrEP
- Arm: Group 2: PrEP Providers and Clinic AdministratorsPrEP providers and clinic administrators - Individuals aged 18 years or older who work as PrEP providers or clinic administrators at outpatient clinics or inpatient settings
- Arm: Group 3: Policy Makers and Program LeadersPolicy makers and program leaders - Individuals aged 18 years or older who work as policy makers or program leaders at outpatient clinics or inpatient settings
Primary Outcome Measure
PrEP Continuation (Aim 2) [ Time Frame: Up to 2 years ]
Central Contacts
- Rena Patel, MD, MPH+12059348145
Find similar trials
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.Recruiting · Syneos Health · Wilmington, North Carolina
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- Skeletal Muscle Energetics and Fatiguability in Older IndividualsRecruiting · Johns Hopkins University · Baltimore, Maryland